Editorial: Refining patient selection for primary prevention implantable cardioverter-defibrillator therapy reeling in a net cast too widely

Circulation

Volumn 120, Issue 10, 2009, Pages 825-827

  Tung, Roderick ^a   Swerdlow, Charles D ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Editorials death; Heart failure; Sudden defibrillation

Indexed keywords

COST EFFECTIVENESS ANALYSIS; DEFIBRILLATOR; EDITORIAL; ELECTROCARDIOGRAM; HEART FAILURE; HEART VENTRICLE TACHYCARDIA; IMPLANTATION; PRIORITY JOURNAL; SUDDEN DEATH; HEART VENTRICLE FIBRILLATION; HUMAN; METHODOLOGY; NOTE; PATIENT SELECTION; PRIMARY PREVENTION; TREATMENT OUTCOME;

DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; HEART FAILURE; HUMANS; MEDICAL FUTILITY; PATIENT SELECTION; PRIMARY PREVENTION; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION;

EID: 70349776500     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.109.891069     Document Type: Editorial

References (24)

1. 1. Moss AJ, Zaieba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-883. (Pubitemid 34984635)
2. 2. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, ClappChanning N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-237. (Pubitemid 40110811)
3. Levy WC, Lee KL, Hellkamp AS, Poole JE, Mozaffarian D, Linker DT, Maggioni AP, Amand I, Poole-Wilson PA, Fishbein DP, Johnson G, Anderson J, Mark DB, Bardy GH. Maximizing survival benefit with primary prevention implantable cardioverter-defibrilator therapy in a heart failure population. Circulation. 2009;120:835-842.
4. 4. Daubert JP, Zareba W, Hall WJ, Schuger C, Corsello A, Leon AR, Andrews ML, McNitt S, Huang DT, Moss AJ. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients. J Am. Coll. Cardiol. 2006;47:98-107. (Pubitemid 43005171)
5. Chow T, Kereiakes DJ, Onufer J, Woelfel A, Gursoy S, Peterson BJ, Brown ML, Pu W, Benditt DG. Does microvolt T-wave altemans testing predict ventricular tachyarrhythmias in patients with ischemic cardiomyopathy and prophylactic defibrillators? The MASTER (Microvolt T Wave Alternans Testing for Risk Stratification of Post-Myocardial Infarction Patients) trial. J Am Coll Cardiol. 2008;52:1607-1615.
6. 6. Mark DB, Nelson CL, Anstrom KJ, Al-Khatib SM, Tsiatis AA, Cowper PA, Clapp-Channing NE, Davidson-Ray L, Poole JE, Johnson G, Anderson J, Lee KL, Bardy GH. Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Circulation. 2006;114:135-142. (Pubitemid 44420745)
7. 7. Zwanziger J, Hall WJ, Dick AW, Zhao H, Mushlin AI, Hahn RM, Wang H, Andrews ML, Mooney C, Moss AJ. The cost effectiveness of implantable cardioverter-defibrillators: results from, the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. J Am. Coll Cardiol. 2006;47:2310-2318. (Pubitemid 43795065)
8. Goldenberg I, Vyas AK, Hall WJ, Moss AJ, Wang H, He H, Zareba W, McNitt S, Andrews ML. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol. 2008;51:288-296.
9. Germano JJ, Reynolds M, Essebag V, Josephson ME. Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic? Am J Cardiol. 2006;97:1255-1261.
10. Tung R, Zimetbaum P, Josephson ME. A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. J Am Coll Cardiol. 2008;52:1111-1121.
11. 11. Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R, Fain E, Gent M, Connolly SJ. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med. 2004;351:2481-2488. (Pubitemid 39603155)
12. Pellegrini CN, Lee K, Olgin JE, Turakhia MP, Tseng ZH, Lee R, Badhwar N, Lee B, Varosy PD. Impact of advanced age on survival in patients with implantable cardioverter defibrillators. Europace. 2008; 10: 1296-1301.
13. 13. Lee DS, Tu JV, Austin PC, Dorian P, Yee R, Chong A, Alter DA, Laupacis A. Effect of cardiac and noncardiac conditions on survival after defibrillator implantation. J Am Coll Cardiol 2007;49:2408-2415. (Pubitemid 46962260)
14. 14. Cuculich PS, Sanchez JM, Kerzner R, Greenberg SL, Sengupta J, Chen J, Faddis MN, Gleva MJ, Smith TW, Lindsay BD. Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death Pacing Clin Electrophysiol. 2007;30: 207-213. (Pubitemid 46333676)
15. 15.AmmanEM,CohenM,BerninkPJ,McCabeCH,HoracekT,PapuchisG,MautnerB, Corbalan.R,RadleyD,BraunwaldE.TheTIMIriskscoreforunstableangina/ non-STelevationMI:amethodforprognosticationandtherapeuticdecisionmaking.JAMA. 2000;284:835-842.(Pubitemid30643610)
16. 16.WilsonPW,D'AgostinoRB,LevyD,BelangerAM,SilbershatzH,KannelWB. Predictionofcoronaryheartdiseaseusingrisk,factorcategories.Circulation.1998;97: 1837-1847.(Pubitemid28213628)
17. 17. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999;353:2001-2007. (Pubitemid 29271744)
18. 18. Sweeney MO, Ruetz LL, Belk P, Mullen TJ, Johnson. JW, Sheldon T. Bradycardia pacing-induced short-long-short sequences at the onset of ventricular tachyarrhythmias: a possible mechanism of proarrhythmia? J Am Coll Cardiol. 2007;50:614-622. (Pubitemid 47199010)
19. Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P, Schuger C, Steinberg JS, Higgins SL, Wilber DJ, Klein H, Andrews ML, Hall WJ, Moss AJ. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol. 2008;51:1357-1365.
20. Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, Reddy RK, Marchlinski FE, Yee R, Guarnieri T, Talajic M, Wilber DJ, Fishbein DP, Packer DL, Mark DB, Lee KL, Bardy GH. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med. 2008;359:1009-1017.
21. Sweeney MO, Wathen MS, Sherfesee L, DeGroot P, Wilkoff BL. Differences in effects of electrical therapy for ventricular arrhythmias on. mortality in ICD patients. Circulation. 2008;118:S672-a.
22. 22. Mitchell LB, Pineda EA, Titus JL, Bartosch PM, Benditt DG. Sudden, death in patients with implantable cardioverter defibrillators: the importance of post-shock electromechanical dissociation. J Am. Coll Cardiol. 2002;39:1323-1328. (Pubitemid 34297872)
23. 23. Wathen MS, DeGroot PJ, Sweeney MO, Stark AJ, Ottemess MF, Adkisson WO, Canby RC, Khalighi K, Machado C, Rubenstein DS, Volosin KJ. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results. Circulation. 2004;110:2591-2596. (Pubitemid 39453007)
24. Wilkoff BL, Williamson BD, Stem RS, Moore SL, Lu F, Lee SW, Birgersdotter-Green UM, Wathen MS, Van Gelder IC, Heubner BM, Brown ML, Holloman KK. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation.) study. J Am Coll Cardiol. 2008;52:541-550.